Washington Post: These laboratory-made antibodies are a best bet for a coronavirus treatment, but there won’t be enough

Washington Post: These laboratory-made antibodies are a best bet for a coronavirus treatment, but there won’t be enough. “Predictions about coronavirus vaccines have become almost deafening in recent weeks, but whether or not the first doses of a vaccine arrive this year, some people will continue to get sick. A medication that could prevent people from progressing to the point that they need a hospital bed or ventilator could be a bridge to a vaccine, or it could be the lifeline that could give people confidence to return to normal life even once vaccines are developed.”

Leave a Reply